News Features PCSK9 Inhibitors: Good Early Responses With Pricey Drugs, but Doctors Still Waiting on Real Data Michael O'Riordan January 25, 2016
News Daily News ACC, AHA Risk-Based Approach Remains Best Method for Statin Allocation in Primary Prevention Michael O'Riordan December 13, 2015
News Daily News Statin Therapy Reduces Influenza Vaccine Effectiveness, Studies Suggest Yael L. Maxwell November 03, 2015
News Daily News Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular Caitlin E. Cox October 27, 2015
News Daily News No Money, No Drugs: Global Barriers to Secondary CVD Prevention Caitlin E. Cox October 27, 2015
Presentation Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries Presenter: R. Khatib October 26, 2015
News Industry News Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union September 28, 2015
News Industry News Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab) September 11, 2015
News Daily News Un Nuevo Inhibidor Antisentido Reduce los Niveles Altos de Triglicéridos August 13, 2015
News Daily News Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients August 06, 2015
News Daily News Una Puntuación de Calcio Igual a 0 Ofrece una ‘Ventaja’ sobre la Mortalidad de 15 Años de Duración en Pacientes Asintomáticos August 06, 2015
Presentation SCCT 2015 Identifying Risk Beyond Stenosis in the ED Lessons Learned from ROMICAT Presenter: Maros Ferencik July 18, 2015
News Industry News Regeneron and Sanofi Announce Phase 3 Results Showing LDL-C Reductions of More Than 60 Percent in Japanese Patients Treated with Praluent® (alirocumab) Injection July 09, 2015
News Daily News In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries June 16, 2015